The reinstatement removes a major overhang and should support near-term price stability. Monitor the next quarterly filing for evidence of the CEO's claimed revenue growth and cost structure improvement. The one-year Panel Monitor means any future non-compliance could trigger immediate delisting.
Price Chart
Executive Summary
BIO-key International announced that Nasdaq has reinstated trading of its common stock on the Nasdaq Capital Market effective July 8, 2026, following a June 16 hearing where the company demonstrated compliance with continued listing standards. The company will remain under a Discretionary Panel Monitor for one year. This removes the immediate delisting overhang and restores exchange liquidity, though no financial details were provided.
Key Facts
- Nasdaq trading resumes on July 8, 2026, on the Nasdaq Capital Market
- Company regained compliance with minimum bid price and SEC filing requirements after a June 16, 2026 hearing
- Subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) until July 6, 2027
- CEO stated expectations for 'significantly improved results' this year, but no financial figures were disclosed
Financial Impact
Removal of delisting risk restores exchange listing and liquidity; no financial impact quantified in the filing
Risk Factors
- Continued Nasdaq monitoring with potential for immediate delisting if compliance lapses within the one-year monitor period
- No financial data provided to substantiate management's optimistic forward-looking statements
- Historical stock volatility and poor prior performance suggest high risk even with positive news
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-022880 |
| Exhibit: ex_985172.htm | 0001437749-26-022880 |
| Document: 0001437749-26-022880-index-headers.html | 0001437749-26-022880 |
| Document: 0001437749-26-022880-index.html | 0001437749-26-022880 |
| Document: 0001437749-26-022880.txt | 0001437749-26-022880 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | S-1 | $1.65 | awaiting T+60 | — | $2.85 (−72.73%) |
Oct 6, 2026 21d ago | DEFA14A | $1.76 | awaiting T+60 | — | $2.85 (+61.93%) |
Oct 6, 2026 21d ago | 8-K | $1.76 | awaiting T+60 | — | $2.85 (+61.93%) |
Oct 2, 2026 25d ago | 8-K | $1.93 | awaiting T+60 | — | $2.85 (−47.67%) |
Sep 29, 2026 28d ago | Press Release | $3.12 | awaiting T+60 | — | $2.85 (−8.65%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $2.85 (+4.04%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $2.85 (+10.38%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $2.85 (−10.38%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $2.85 (−31.65%) |
Jul 28, 2026 13w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $2.85 (−32.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers